Sepsis Clinical Trial
— PS-PICSOfficial title:
Peer Support for Post Intensive Care Syndrome Self-Management (PS-PICS)
Verified date | October 2020 |
Source | University of Texas at Austin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design is planned. Forty CCI survivors will be randomized (1:1) to either the PS-PICS (peer support) intervention or usual care (control) group.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | January 27, 2021 |
Est. primary completion date | October 27, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - age18 years or older - ICU length of stay 8 days or longer - expected to survive hospitalization with a discharge destination to home within 28 days of hospital discharge - diagnosed with 2 or more chronic conditions. Exclusion Criteria: - death prior to hospital discharge - enrollment in Hospice services at the time of hospital discharge - non-communicative - no access to telephone - incarcerated |
Country | Name | City | State |
---|---|---|---|
United States | Baylor Scott & White Health | Temple | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Texas at Austin |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Health services utilization | Utilization of health services | 1-week Post-intervention | |
Other | Health services utilization | Utilization of health services | 3 months post intervention | |
Primary | Social Network Index | Social Network Index (SNI) to measure social relationships. The scale range is 0-12. The total score will be reported. The maximum total score is 12. Higher values represent a broader diversity of social networks and are classified as a better outcome. | 3 months post-intervention | |
Secondary | Center for Epidemiologic Studies Depression Scale (CES-D) | Center for Epidemiologic Studies Depression Scale (CES-D) to measure self-reported symptoms of depression The scale range is 0-60. The total score will be reported. The maximum total score is 60. Higher values represent self-reported symptoms of depression. Higher values represent a worse outcome. | 1-week Post-intervention | |
Secondary | Center for Epidemiologic Studies Depression Scale (CES-D) | Center for Epidemiologic Studies Depression Scale (CES-D) to measure self-reported symptoms of depression The scale range is 0-60. The total score will be reported. The maximum total score is 60. Higher values represent self-reported symptoms of depression. Higher values represent a worse outcome. | 3 months post-intervention | |
Secondary | Social Network Index | Social Network Index (SNI) to measure social relationships. The scale range is 0-12. The total score will be reported. The maximum total score is 12. Higher values represent a broader diversity of social networks and are classified as a better outcome. | 1-week Post-intervention | |
Secondary | Patient Activation Measure | Patient Activation Measure (PAM) Survey to measure self-reported active behavior in the self-management of chronic illness.
The scale range is 0-100. The total score will be reported. The maximum total score is 100. Higher values represent high levels of activation in self-management. Higher values represent a better outcome. |
1-week Post-intervention | |
Secondary | Patient Activation Measure | Patient Activation Measure (PAM) Survey to measure self-reported active behavior in the self-management of chronic illness.
The scale range is 0-100. The total score will be reported. The maximum total score is 100. Higher values represent high levels of activation in self-management. Higher values represent a better outcome. |
3 months post-intervention | |
Secondary | Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale | Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale The scale range is 0-65. The total score will be reported. For each scale range provided, specify which values are considered to be a better or worse outcome (e.g., Do higher values represent a better or worse outcome?).
The maximum total score is 65. Higher values represent higher levels of fatigue. |
1-week Post-intervention | |
Secondary | Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale | The Measure includes a scale. Please provide the following scale information:
Specify the full (unabbreviated) scale name and construct (i.e., indicate what the scale measures if not clear from name). Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale Include all scale ranges (i.e., minimum and maximum scores) required to interpret any values. For example, if the *total* score is reported, the *total* range should be provided. If *subscale* scores are reported, the range for each *subscale* should be provided. The scale range is 0-65. The total score will be reported. For each scale range provided, specify which values are considered to be a better or worse outcome (e.g., Do higher values represent a better or worse outcome?). The maximum total score is 65. Higher values represent higher levels of fatigue. If subscales are combined to compute a total score, consider indicating how subscales are combined (summed, averaged, etc.). N/A |
3 months post-intervention | |
Secondary | Short Form-36 (SF-36) | Short Form-36 (SF-36) or 36-Item Short Form Health Survey Instrument The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100.
Lower scores = more disability, higher scores = less disability Sections: · Vitality · Physical functioning · Bodily pain · General health perceptions · Physical role functi |
1-week Post-intervention | |
Secondary | Short Form-36 (SF-36) | Short Form-36 (SF-36) or 36-Item Short Form Health Survey Instrument The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100.
Lower scores = more disability, higher scores = less disability Sections: · Vitality · Physical functioning · Bodily pain · General health perceptions · Physical role functi |
3 months post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |